The HCPLive endocrinology page is a comprehensive resource for clinical news and insights on endocrine system conditions. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for diabetes, hormonal disease, and more.
September 18th 2024
The FDA has approved the Eversense 365, the world’s first 1-year continuous glucose monitor, with US availability expected in late 2024.
September 7th 2024
HCPLive Endocrinology's flagship diabetes podcast, hosted by Diana Isaacs, PharmD, and Natalie Bellini, DNP
Denosumab: Can RANKL Inhibition Improve Insulin Resistance?
April 22nd 2015With more than 40 million Americans either diagnosed or at high risk for osteoporosis as they age, researchers are scrambling to find ideal preventive and curative agents. One target that strengthens bones is excessive osteoclast activity. A team of researchers recently found that one biologic that targets excessive osteoclast activity may positively influence another problem of later life: insulin sensitivity.
Glycated Albumin: The Next HgA1c?
April 15th 2015Albumin -- the most abundant protein in the human body -- has many roles. It transports hormones, fatty acids, and other compounds. It buffers serum pH, and maintains osmotic pressure. Now, it appears that albumin may be a tool that could be used in diabetes management.
FDA Panel Recommends Adding New Safety Warnings to Labels of 3 Diabetes Drugs
An advisory panel for the US Food and Drug Administration (FDA) held a hearing yesterday focusing on safety issues associated with two diabetes medications. Although the panel's recommendation did not include specific treatment changes, its decision highlighted the fact that more research is needed on cardiovascular risk associated with this class of diabetes medications.
Body Mass Index Shows Potential Link to Dementia
There has been considerable research regarding the unhealthy risks associated with being overweight later in life. A recent study has shown that being underweight can also have a negative effect on a person's life as they get older.
Chronic Kidney Disease: Sleep Problems Increases with Disease Progression
April 13th 2015Lack of sleep and chronic kidney disease (CKD) independently lead to hypertension, diabetes mellitus, lower quality of life, and shorter life expectancy. Severity of CKD and sleep disturbances may also worsen diabetes and hypertension synergistically.
Calcium Sensing Receptor Activators: A Decade of Study, A Bright Future
April 13th 2015Secondary hyperparathyroidism is common in dialysis patients due to impaired vitamin D activation. An article published in the 2015 issue of Seminars in Dialysis surveys the past decade's findings about use of calcium sensing receptor activators-also called calcimimetics-in this population.
TORe Procedure Blazes New Path for Gastric Bypass Patients Part 4
While TORe has been a significant development in the treatment of overweight and obese patients who have undergone gastric bypass surgery there are more procedures on the horizon that could provide even greater benefits in the future.
TORe Procedure Blazes New Path for Gastric Bypass Patients Part 3
Even more so than gastric bypass surgery, the work of the patient determines how effective TORe can be in helping them keep from re-gaining excess weight. With diet, exercise, and working with their healthcare professionals the results can be positive for everyone involved.
TORe Procedure Blazes New Path for Gastric Bypass Patients Part 2
While gastric bypass has provided benefits for millions of patients it has not been without its share of complications and difficulties after the procedure. Over the past few years work has been done to find ways to help patients after undergoing the original operation.
TORe Procedure Blazes New Path for Gastric Bypass Patients
Across the country millions of people have undergone gastric bypass surgery in an effort to lose weight and improve their overall health. For those patients who have seen their results diminish a relatively new procedure could get them back on the road to a healthy lifestyle.
Obesity: A 'Super-size" Problem
April 8th 2015Although the obesity epidemic in the United States seems to have reached a plateau over the past few years, the prevalence of obesity continues to be high with 30% of Americans classified as obese, defined as having a BMI of 30 kg/m2 or more, and an additional 30% overweight, with a BMI of 25 to 29.9 kg/m2.
Insulin Resistance Higher in Rheumatoid Arthritis Patients
The increased insulin resistance seen in rheumatoid arthritis (RA) patients compared to non-RA controls did not contribute to additional atherosclerosis risk, according to research published in Arthritis & Rheumatology.
Newly Diagnosed Diabetes Cases Rise after Medicaid Expansion Spurs Patient Testing
In states that expanded the number of low-income people eligible for Medicaid under the Affordable Care Act, the number of people with newly diagnosed type 2 diabetes increased by 23 percent.
Fish Consumption and ACS: A Meta-Analysis
March 30th 2015The American Heart Association was one of the first organizations to advocate dietary changes to decrease the risk of coronary heart disease (CHD). The organization's first recommendation appeared in 1957 advising a decrease in the amount of fat intake to decrease atherosclerosis risk. Today, a different approach is recommended, which considers the diet as a whole, with recommendations of what to both include and avoid. Among other nutritional and lifestyle recommendations, the AHA advises the consumption of 2 servings of fish weekly for both men and women.
BMI and the Risk of All-Cause Mortality Among Patients with Type 2 Diabetes Mellitus
March 30th 2015Studies have identified lower-than-normal BMIs to be associated with higher mortality in comparison with normal body weight and overweight individuals in patients with coronary artery disease. This has given rise to the term "obesity paradox" in which being overweight/obese confers a survival advantage in individuals that have been diagnosed with a medical condition. Against this backdrop, this study attempted to evaluate whether there is an association between BMI and death risk among patients with type 2 diabetes mellitus.